Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001999371-25-011639
Filing Date
2025-08-19
Accepted
2025-08-19 09:12:00
Documents
2
Group Members
CONCENTRA MERGER SUB VII, INC.TANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC TO-T cargo-sctota_081925.htm SC TO-T/A 42374
2 CONTINGENT VALUE RIGHTS AGREEMENT ex99-d6.htm EX-99.(D)(6) 188749
  Complete submission text file 0001999371-25-011639.txt   232828
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Subject) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-94225 | Film No.: 251229811
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 210 SAN DIEGO CA 92121 8582003830
Concentra Biosciences, LLC (Filed by) CIK: 0001970065 (see all company filings)

EIN.: 922825109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A